CVRM Research 2025 Wrapped

Please join Dr Xenophon Kassianides, Prof Derek Connolly and Dr Rani Khatib for a comprehensive recap of the progress in CVRM medicine during 2025:Outlining antiplatelet drugs and beta blockers post ACSDiscussing the ESC guidelines update on cholesterol management, the importance of a full lipid profile and the evidence for combination therapyThe evolving market of antihypertensive drugsThe obesity pandemic, how GLP-1’s support weight loss, highlighting the need for concurrent proactive health management including exercise and risk modificationIf you are a UK practising healthcare professional and would like to learn more about cardiovascular disease (CVD), please take a look at our online CVD academy here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join the PCCS | Primary Care Cardiovascular Society⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠________________This podcast is intended for UK Healthcare professionals only. The information provided in this presentation is for educational purposes only. Prescribing or management decisions made by clinicians are exclusively their own responsibility. The speaker/PCCS bear no responsibility regarding management or prescribing decisions made by others, or otherwise.If you have any concerns about any personal health related issues discussed in this podcast, please consult with your own GP.Speakers declarations can be found on our website ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here.⁠